GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Ending Cash Position

Poxel (XPAR:POXEL) Ending Cash Position : €7.60 Mil (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Ending Cash Position?

Poxel's Ending Cash Position for the quarter that ended in Jun. 2023 was €7.60 Mil.

Poxel's quarterly Ending Cash Position declined from Jun. 2022 (€16.14 Mil) to Dec. 2022 (€13.06 Mil) and declined from Dec. 2022 (€13.06 Mil) to Jun. 2023 (€7.60 Mil).

Poxel's annual Ending Cash Position declined from Dec. 2020 (€40.20 Mil) to Dec. 2021 (€32.29 Mil) and declined from Dec. 2021 (€32.29 Mil) to Dec. 2022 (€13.06 Mil).

Poxel Ending Cash Position Historical Data

The historical data trend for Poxel's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Ending Cash Position Chart

Poxel Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.74 37.19 40.20 32.29 13.06

Poxel Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.92 32.29 16.14 13.06 7.60

Poxel Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Poxel's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=32.287+-19.229
=13.06

Poxel's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=13.058+-5.461
=7.60

Poxel Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Poxel's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Poxel Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Ending Cash Position
Comparable Companies
XPAR:FALG XPAR:ALHYG XPAR:ALCOX XPAR:ALTHX XPAR:ALNFL XPAR:ALPAT XPAR:ALINT XPAR:ALVET XPAR:SIGHT XPAR:ALBPS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0RA2:UK 7PO:Germany
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Website
https://www.poxel.com
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel Headlines

No Headlines